NanoString-based breast cancer risk prediction for women with sclerosing adenosis.
Stacey J WinhamChristine MehnerEthan P HeinzenBrendan T BroderickMelody Stallings-MannAziza NassarRobert A VierkantTanya L HoskinRyan D FrankChen WangLori A DenisonCeline M VachonMarlene H FrostLynn C HartmannE Aubrey ThompsonMark E ShermanDaniel W VisscherAmy C DegnimDerek C RadiskyPublished in: Breast cancer research and treatment (2017)
Our results demonstrate that biomarkers of breast cancer risk can be detected in benign breast tissue years prior to cancer development in women with SA. These markers can be assessed using assay methods optimized for RNA derived from FFPE biopsy tissues which are commonly available.